(6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methanamine hydrochloride, 97%, 250mg

4-[(4-acetylpiperazin-1-yl)carbonyl]benzoic acid, 95.0%, 500mg

MTT [for Biochemical Research]>97.0%(HPLC)1g

2,6-Dibromo-N,N'-di-n-octyl-1,8:4,5-naphthalenetetracarboxdiimide>98.0%(HPLC)5g

2-(1-METHYL-1H-IMIDAZOL-4-YL)ETHAN-1-AMINE, 95.0%, 250mg

1H-Indole-1-carboxamide, 6-chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-, 99%, 10mg

ETHYL-3-PHENYL PYRAZOLE-4-CARBOXYLATE, 95.0%, 5g

Volumetric flasks class B crystal clear, 500 ml, 19/26, 2 Piece(s)

4-Toluenesulfonylacetic acid, 98.0%, 25g

2,4-Dichlorofluorobenzene>96.0%(GC)500g

2-(2-Chlorophenyl)piperazine, 97.0%, 100mg

2-Methylpropylhydrazine hydrochloride, 95.0%, 1g